Challenges in utilizing ALK expression to distinguish primary cutaneous from systemic anaplastic large cell lymphoma

By sjmartinez • April 10, 2024

Gleason L, Afifi L, Banner L, Talasila S, Joffe D, Bhatti S, Alpdogan O, Porcu P, Nikbakht N. Challenges in utilizing ALK expression to distinguish primary cutaneous from systemic anaplastic large cell lymphoma. Mol Clin Oncol. 2024 Mar 19;20(5):35. doi: 10.3892/mco.2024.2733. PMID: 38596625; PMCID: PMC11002836.

Tags: anaplastic large cell, anaplastic lymphoma kinase, CD30+, Dermatology, lymphoma, primary cutaneous anaplastic large cell lymphoma, Publications, Resident, systemic anaplastic large cell lymphoma

Treatment of severe perinuclear antineutrophil cytoplasmic antibody-associated vasculitis with efgartigimod

Ghafari-Saravi A, Haussmann A, Wu J, Cheng K. Treatment of severe perinuclear antineutrophil cytoplasmic antibody-associated vasculitis with efgartigimod. JAAD Case Rep. 2024 Mar 15;47:68-71. doi:[...]

Stigmatization and Mental Health Impact of Chronic Pediatric Skin Disorders

Paller AS, Rangel SM, Chamlin SL, Hajek A, Phan S, Hogeling M, Castelo-Soccio L, Lara-Corrales I, Arkin L, Lawley LP, Funk T, Castro Porto Silva[...]

Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60

Egeberg A, Hawkes JE, Somani N, Burge R, See K, Gallo G, McKean-Matthews M, Gooderham M, Han G, Armstrong A. Sustained Improvements in Clinical and[...]